These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20807222)

  • 1. Synthetic peptide vaccine development: designing dual epitopes into a single pilin peptide immunogen generates antibody cross-reactivity between two strains of Pseudomonas aeruginosa.
    Hackbarth C; Hodges RS
    Chem Biol Drug Des; 2010 Oct; 76(4):293-304. PubMed ID: 20807222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advantages of a synthetic peptide immunogen over a protein immunogen in the development of an anti-pilus vaccine for Pseudomonas aeruginosa.
    Kao DJ; Hodges RS
    Chem Biol Drug Des; 2009 Jul; 74(1):33-42. PubMed ID: 19519742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-antibody interactions: elucidation of the epitope and strain-specificity of a monoclonal antibody directed against the pilin protein adherence binding domain of Pseudomonas aeruginosa strain K.
    Wong WY; Irvin RT; Paranchych W; Hodges RS
    Protein Sci; 1992 Oct; 1(10):1308-18. PubMed ID: 1284654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptide vaccine development: measurement of polyclonal antibody affinity and cross-reactivity using a new peptide capture and release system for surface plasmon resonance spectroscopy.
    Cachia PJ; Kao DJ; Hodges RS
    J Mol Recognit; 2004; 17(6):540-57. PubMed ID: 15386623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological studies of the disulfide bridge region of Pseudomonas aeruginosa PAK and PAO pilins, using anti-PAK pilus and antipeptide antibodies.
    Lee KK; Sastry PA; Paranchych W; Hodges RS
    Infect Immun; 1989 Feb; 57(2):520-6. PubMed ID: 2563257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal protection and structural studies of a consensus sequence vaccine targeting the receptor binding domain of the type IV pilus of Pseudomonas aeruginosa.
    Kao DJ; Churchill ME; Irvin RT; Hodges RS
    J Mol Biol; 2007 Nov; 374(2):426-42. PubMed ID: 17936788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the receptor binding domains of Pseudomonas aeruginosa pili strains PAK, PAO, KB7 and P1 to a cross-reactive antibody and receptor analog: implications for synthetic vaccine design.
    Campbell AP; Wong WY; Houston M; Schweizer F; Cachia PJ; Irvin RT; Hindsgaul O; Hodges RS; Sykes BD
    J Mol Biol; 1997 Mar; 267(2):382-402. PubMed ID: 9096233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of a peptide from the receptor-binding domain of Pseudomonas aeruginosa pili strain PAK with a cross-reactive antibody: changes in backbone dynamics induced by binding.
    Campbell AP; Spyracopoulos L; Wong WY; Irvin RT; Sykes BD
    Biochemistry; 2003 Sep; 42(38):11334-46. PubMed ID: 14503884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of a bacterially expressed peptide from the receptor binding domain of Pseudomonas aeruginosa pili strain PAK with a cross-reactive antibody: conformation of the bound peptide.
    Campbell AP; Wong WY; Irvin RT; Sykes BD
    Biochemistry; 2000 Dec; 39(48):14847-64. PubMed ID: 11101301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence of Pseudomonas aeruginosa and Candida albicans to glycosphingolipid (Asialo-GM1) receptors is achieved by a conserved receptor-binding domain present on their adhesins.
    Yu L; Lee KK; Hodges RS; Paranchych W; Irvin RT
    Infect Immun; 1994 Dec; 62(12):5213-9. PubMed ID: 7525482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa.
    Hughes EE; Gilleland LB; Gilleland HE
    Infect Immun; 1992 Sep; 60(9):3497-503. PubMed ID: 1379985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactive and strain-specific antipeptide antibodies to Pseudomonas aeruginosa PAK and PAO pili.
    Lee KK; Paranchych W; Hodges RS
    Infect Immun; 1990 Sep; 58(9):2727-32. PubMed ID: 1974884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of synthetic peptides in the design of a consensus sequence vaccine for Pseudomonas aeruginosa.
    Cachia PJ; Glasier LM; Hodgins RR; Wong WY; Irvin RT; Hodges RS
    J Pept Res; 1998 Oct; 52(4):289-99. PubMed ID: 9832307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilin-based anti-Pseudomonas vaccines: latest developments and perspectives.
    Hahn H; Lane-Bell PM; Glasier LM; Nomellini JF; Bingle WH; Paranchych W; Smit J
    Behring Inst Mitt; 1997 Feb; (98):315-25. PubMed ID: 9382755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopotentiation of the engineered low-molecular-weight pilin targeting Pseudomonas aeruginosa: A combination of immunoinformatics investigation and active immunization.
    Ahmadbeigi Y; Chirani AS; Soleimani N; Mahdavi M; Goudarzi M
    Mol Immunol; 2020 Aug; 124():70-82. PubMed ID: 32540517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pseudomonas aeruginosa type IV pilin receptor binding domain functions as an adhesin for both biotic and abiotic surfaces.
    Giltner CL; van Schaik EJ; Audette GF; Kao D; Hodges RS; Hassett DJ; Irvin RT
    Mol Microbiol; 2006 Feb; 59(4):1083-96. PubMed ID: 16430686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution secondary structure of a bacterially expressed peptide from the receptor binding domain of Pseudomonas aeruginosa pili strain PAK: A heteronuclear multidimensional NMR study.
    Campbell AP; Bautista DL; Tripet B; Wong WY; Irvin RT; Hodges RS; Sykes BD
    Biochemistry; 1997 Oct; 36(42):12791-801. PubMed ID: 9335536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of the adherence-binding domain on the pilin of Pseudomonas aeruginosa strains PAK and KB7.
    Wong WY; Campbell AP; McInnes C; Sykes BD; Paranchych W; Irvin RT; Hodges RS
    Biochemistry; 1995 Oct; 34(40):12963-72. PubMed ID: 7548054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection.
    Horzempa J; Held TK; Cross AS; Furst D; Qutyan M; Neely AN; Castric P
    Clin Vaccine Immunol; 2008 Apr; 15(4):590-7. PubMed ID: 18272666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.